SF-NETT: San Francisco Neurological Emergencies Trials Network
SF-NETT:旧金山神经紧急试验网络
基本信息
- 批准号:8396945
- 负责人:
- 金额:$ 29.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-03 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlteplaseAmbulancesBrainCaliforniaCaringCerebral IschemiaChairpersonCharacteristicsClinicalClinical ResearchClinical TreatmentClinical TrialsCommunity HospitalsDestinationsDevelopmentEMSAEarly treatmentEffectivenessEmergency MedicineEmergency SituationEmergency treatmentEncephalitisEnrollmentEnsureFacultyFosteringFundingGeneral HospitalsGoalsHawaiian populationHeart ArrestHeterogeneityHospitalsHourHuman ResourcesInterdisciplinary StudyInterventionIschemic StrokeLatinoLearningLogisticsMaintenanceMedical centerMeningitisMinorityModelingNational Institute of Neurological Disorders and StrokeNervous system structureNeurological emergenciesOutcomePathway interactionsPatientsPhasePhase III Clinical TrialsPhysiciansPopulationPopulation HeterogeneityPublic HealthPublishingRefractoryResearchResearch InfrastructureResearch PersonnelResearch SubjectsSan FranciscoSeizuresStandardizationStatus EpilepticusStrokeSystemTimeTissuesTrainingTransient Ischemic AttackTraumatic Brain InjuryUnderrepresented MinorityUniversitiesWorkWritingacute strokebasecareer developmenteffective therapyexperienceflexibilityimprovedmembermultidisciplinaryneonatal hypoxic-ischemic brain injuryneuromuscularnext generationprogramsspinal cord and brain injurytrauma centerstreatment trial
项目摘要
DESCRIPTION (provided by applicant): Neurological emergencies comprise a wide range of conditions which include refractory seizures, acute stroke, traumatic brain and spinal cord injury,
meningitis and encephalitis, hypoxic-ischemic encephalopathy, and acute neuromuscular conditions. While these may initially appear to represent disparate conditions, they share two important characteristics: earlier treatment is likely necessary to improve patient outcome and logistics of initial patient presentation pose major challenges to clinical trials of treatments fo these conditions. The NINDS Neurological Emergencies Treatment Trials Network has created a national network of hub and spoke hospital systems to facilitate the conduct of streamlined clinical trials for neurological emergencies such as these. SF-NETT: the San Francisco Neurological Emergencies Trials network has been a high-enrolling hub-spoke system during the first 5-year NETT cycle. SF-NETT represents a scalable and flexible network which can be configured and activated to maximize enrollment of eligible patients across a wide range of conditions being studied. Consisting of all San Francisco ambulance destination hospitals, as well as three specially selected geographically non-contiguous spokes (UCSF-Fresno, Queen's Medical Center, and UC Davis), SF-NETT represents a consortium of academic and community hospitals with a catchment population exceeding 4 million. San Francisco General Hospital is a trauma center, stroke center, the SF-EMSA base hospital, and serves as the hub of SF-NETT. Between the hub and participating spoke hospitals, there are 4 designated trauma centers, 7 comprehensive stroke centers, and 4 EMS systems. SF-NETT works directly with NINDS and the NETT Clinical Coordinating Center to conduct multiple concurrent clinical trials of neurological emergencies via the network, with four trials initiated (one completed) during the initial 5-year cycle. This application is for the 5-year renewal of SF-NETT as a hub for the national NETT network.
PUBLIC HEALTH RELEVANCE: Neurological emergencies such as refractory seizures, stroke, and neurotrauma have a major impact on public health and are the challenging conditions to study because of the need for early intervention. The NETT network has proven to be an efficient system in which to conduct these trials and SF-NETT has been a high-enrolling active hub during the initial 5-year program cycle.
描述(由申请人提供):神经急症包括范围广泛的情况,包括难治性癫痫发作,急性中风,创伤性脑和脊髓损伤,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JESSE Claude HEMPHILL其他文献
JESSE Claude HEMPHILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JESSE Claude HEMPHILL', 18)}}的其他基金
SF-NETT: San Francisco Neurological Emergencies Trials Network
SF-NETT:旧金山神经紧急试验网络
- 批准号:
8520402 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NET: San Francisco Neurological Emergencies Trials Network
SF-NET:旧金山神经紧急试验网络
- 批准号:
7255154 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NETT: San Francisco Neurological Emergencies Trials Network
SF-NETT:旧金山神经紧急试验网络
- 批准号:
8852195 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NET: San Francisco Neurological Emergencies Trials Network
SF-NET:旧金山神经紧急试验网络
- 批准号:
7417498 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NET: San Francisco Neurological Emergencies Trials Network
SF-NET:旧金山神经紧急试验网络
- 批准号:
7807902 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NETT: San Francisco Neurological Emergencies Trials Network
SF-NETT:旧金山神经紧急试验网络
- 批准号:
8726493 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NET: San Francisco Neurological Emergencies Trials Network
SF-NET:旧金山神经紧急试验网络
- 批准号:
7631218 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
SF-NET: San Francisco Neurological Emergencies Trials Network
SF-NET:旧金山神经紧急试验网络
- 批准号:
8069147 - 财政年份:2007
- 资助金额:
$ 29.78万 - 项目类别:
相似海外基金
AcT-Cog: Online cognitive assessment in the Alteplase compared to Tenecteplase (AcT) trial.
AcT-Cog:阿替普酶与替奈普酶 (AcT) 试验相比的在线认知评估。
- 批准号:
444794 - 财政年份:2021
- 资助金额:
$ 29.78万 - 项目类别:
Operating Grants
INTERRAcT: Thrombus characteristics for predicting Reperfusion with Alteplase compared to Tenecteplase
INTERRAcT:与替奈普酶相比,阿替普酶预测再灌注的血栓特征
- 批准号:
433102 - 财政年份:2020
- 资助金额:
$ 29.78万 - 项目类别:
Operating Grants
Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke: QuICR & OPTIMISE Registry based Pragmatic Randomized Controlled Trial
阿替普酶与替奈普酶治疗急性缺血性中风患者的比较:QuICR
- 批准号:
401715 - 财政年份:2019
- 资助金额:
$ 29.78万 - 项目类别:
Operating Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : 1079696 - 财政年份:2015
- 资助金额:
$ 29.78万 - 项目类别:
Project Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : GNT1079696 - 财政年份:2015
- 资助金额:
$ 29.78万 - 项目类别:
Project Grants
Low-Dose Tenecteplase vs Standard-Dose Alteplase for Acute Ischaemic Stroke: An Imaging Based Safety and Efficacy Study
低剂量替奈普酶与标准剂量阿替普酶治疗急性缺血性中风:一项基于影像学的安全性和有效性研究
- 批准号:
nhmrc : 510722 - 财政年份:2008
- 资助金额:
$ 29.78万 - 项目类别:
NHMRC Project Grants
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8565339 - 财政年份:
- 资助金额:
$ 29.78万 - 项目类别:
Treament of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
7593114 - 财政年份:
- 资助金额:
$ 29.78万 - 项目类别:
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8952839 - 财政年份:
- 资助金额:
$ 29.78万 - 项目类别:














{{item.name}}会员




